RAKOVINA Logo Mar2021.png
Rakovina Therapeutics: Reflecting on 2024 Success and Building Momentum for a Transformative 2025
19 déc. 2024 07h55 HE | Rakovina Therapeutics Inc
VANCOUVER, British Columbia, Dec. 19, 2024 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (“Rakovina” or the “Company”) (TSX-V: RKV) a biopharmaceutical company focused on the development of new...
RAKOVINA Logo Mar2021.png
Rakovina Announces Debentureholder Election to Receive Shares in Partial Satisfaction of Debenture Interest Payment Obligations
17 déc. 2024 21h55 HE | Rakovina Therapeutics Inc
VANCOUVER, British Columbia, Dec. 17, 2024 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (“Rakovina” or the “Company”) (TSX-V: RKV) announces that in accordance with the terms of an indenture...
RAKOVINA Logo Mar2021.png
Rakovina Therapeutics Announces Closing of Oversubscribed $3M Private Placement
13 déc. 2024 18h50 HE | Rakovina Therapeutics Inc
VANCOUVER, British Columbia, Dec. 13, 2024 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV, the “Company”, “Rakovina”, or “Rakovina Therapeutics”) a biopharmaceutical company committed to...
RAKOVINA Logo Mar2021.png
Rakovina Therapeutics Announces Presentation at the 13th Annual Tumour Models London Summit
03 déc. 2024 07h35 HE | Rakovina Therapeutics Inc
VANCOUVER, British Columbia, Dec. 03, 2024 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV) (“Rakovina” or the “Company”), a biopharmaceutical company committed to advancing new cancer...
RAKOVINA Logo Mar2021.png
Rakovina Therapeutics Increases Private Placement Offering to $3.0 Million
02 déc. 2024 18h22 HE | Rakovina Therapeutics Inc
VANCOUVER, British Columbia, Dec. 02, 2024 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV, the “Company” or “Rakovina Therapeutics”) a biopharmaceutical company committed to advancing...
RAKOVINA Logo Mar2021.png
Rakovina Therapeutics Announces 2024 Q3 Financial Results and Provides Corporate Update
29 nov. 2024 20h40 HE | Rakovina Therapeutics Inc
VANCOUVER, British Columbia, Nov. 29, 2024 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV, the “Company”) a biopharmaceutical company committed to advancing new cancer therapies based on...
RAKOVINA Logo Mar2021.png
Rakovina Therapeutics Announces Increase in Private Placement Offering to $2.5 Million
28 nov. 2024 23h00 HE | Rakovina Therapeutics Inc
VANCOUVER, British Columbia, Nov. 28, 2024 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV, the “Company” or “Rakovina Therapeutics”) a biopharmaceutical company committed to advancing...
RAKOVINA Logo Mar2021.png
Rakovina Therapeutics Announces Private Placement Offering
27 nov. 2024 21h33 HE | Rakovina Therapeutics Inc
VANCOUVER, British Columbia, Nov. 27, 2024 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV, the “Company” or “Rakovina Therapeutics”) a biopharmaceutical company committed to advancing...
RAKOVINA Logo Mar2021.png
Rakovina Therapeutics Presents AI-Driven Drug Discovery Research at Society for Neuro-Oncology Annual Meeting
25 nov. 2024 07h30 HE | Rakovina Therapeutics Inc
VANCOUVER, British Columbia, Nov. 25, 2024 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV) (“Rakovina” or the “Company”), a biopharmaceutical company committed to advancing new cancer...
RAKOVINA Logo Mar2021.png
Rakovina Therapeutics Announces Upcoming Poster Presentation at the 29th Annual Society for Neuro-Oncology Meeting in Houston, Texas
20 nov. 2024 16h30 HE | Rakovina Therapeutics Inc
VANCOUVER, British Columbia, Nov. 20, 2024 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV) (“Rakovina” or the “Company”), a biopharmaceutical company committed to advancing new cancer...